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Abstract
Background—Injection drug users (IDUs) in resource poor settings are at high risk for HIV
transmission through unsafe needle-sharing and sexual practices. We report on the injecting and
sexual behavior of a sample of IDUs from Malindi, Kenya.
Methods—A Priority for Local AIDS Control Efforts (PLACE) study was conducted from April
to May 2010 to identify areas where HIV transmission is most likely to occur and specific venues
where people meet new sexual partners. Community informants (n=202) listed 157 unique venues
from which 29 were randomly selected using a systematic fixed interval sampling strategy with
probability of selection proportional to venue size. Twenty patrons and four workers were
interviewed at each venue. Drug use practices were elicited in a staff-administered interview.
Results—Between 40% and 50% of IDUs reported needle-sharing, taking drugs from a common
reservoir, using a ready-made solution without boiling, and not exchanging a used for a new
syringe in the past month. Most could inconsistently or never get new syringes. In multivariate
logistic regression models controlling for age, education, residence, and poverty status, IDUs were
twice as likely as non-IDUs to report multiple partners in the past year (OR 1.94, 95% CI 1.26 –
3.00, p < .01) and multiple new partners in the past year (OR 2.11, 95% CI 1.30 – 3.42, p < .01).
Conclusions—High prevalence of multiple sexual partnerships and risky injecting behaviors
among IDUs and unavailability of new injecting needles are likely facilitating HIV transmission in
Malindi, Kenya.
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1. Introduction
Although the published epidemiological literature is limited, evidence suggests injection
drug use is becoming increasingly common in sub-Saharan Africa (SSA) (United Nations
Office on Drugs and Crime, 2010a). It is already well-established in Kenya, Mauritius,
South Africa, Nigeria, and Tanzania, with estimated prevalence rates between 0.5% and 1%
in Kenya and South Africa and exceeding 2% on the island of Mauritius, though
remarkably, only three of 47 SSA countries have reliable national prevalence data (Mathers
et al., 2008; United Nations Office on Drugs and Crime, 2010a). Several factors presage its
more widespread development in the region, including an increase in transit of illicit drugs
(heroin from Asia and cocaine from South America) into Europe through SSA countries
with unmonitored and porous borders (United Nations Office on Drugs and Crime, 2010b),
and endemic cofactors such as socioeconomic hardship, political instability, and exposure to
conflicts.
Limited data on IDU behaviors in SSA indicates sharing injecting equipment is common;
access to clean water for cleaning equipment and mixing injecting solutions is limited; and
many do not self-identify as injection drug users (IDUs), some repeatedly switching between
injecting and non-injecting modes (United Nations Office on Drugs and Crime, 2010a). And
although even fewer studies report on prevalence of HIV among IDUs (Mathers et al.,
2008), SSA is home to two-thirds of people living with HIV/AIDS or 22.5 million people
(Joint United Nations Programme on HIV/AIDS, 2010), with prevalence rates well above
2% in 14 of the 16 countries where injecting drug use has been reported (United Nations
Office on Drugs and Crime, 2010a). Given the high regional HIV prevalence and the
efficiency of HIV transmission per injection – six times higher than for heterosexual acts
(United Nations Office on Drugs and Crime, 2005) – HIV prevalence among IDUs can
rapidly reach very high levels (more than 50% and up to 90%) (United Nations Office on
Drugs and Crime, 2010a). Research in African countries has found HIV prevalence among
IDUs far exceeding that in the general population, ranging from 9% to 50% (Needle et al.,
2006). Further, IDUs have been identified as a bridging population (Beckerleg and Hundt,
2004; Stimson and Choopanya, 1998) with an important role in spreading HIV to the general
population through transmission to sexual partners and vertically from mother to child.
In Kenya, IDU has been confirmed in Nairobi, Mombasa, Malindi, and Lamu (the latter
three in Coast province). HIV prevalence among heroin users was reported to be 35%
(Odek-Ogunde et al., 2004), and another study indicated a prevalence approximately five
times that of the general population (Deveau et al., 2006). According to a modes of
transmission (MoT) study in Kenya, the percent of new infections attributable to IDU is
3.8% nationally, 5.8% in Nairobi, and 6.1% in Coast Province (National AIDS Control
Council, 2009). Although the percent of incident cases attributable to IDU is relatively low,
modeling indicates that the incidence rates in the Kenyan HIV epidemic are highest among
IDU at 256 per 1,000 (or 25.6%), followed by MSM in prison (126/1,000), partners of IDU
(78/1,000), and MSM (67/1000). Besides the highly efficient transmission through needle-
sharing and other risky practices, the high incidence rate in IDUs reflects marginalization
and inaccessibility of targeted interventions in this group (National AIDS Control Council,
2009).
Brodish et al. Page 2













Several studies indicate that IDUs are at high risk for HIV transmission through unsafe
practices such as sharing non-sterile injecting equipment and unprotected sex (McCurdy et
al., 2005; Ndetei, 2004; Odek-Ogunde et al., 2004; Parry et al., 2009). Prior research on
IDUs in countries with similar profiles (e.g., Tanzania, Mozambique, and South Africa) has
typically focused on distinct high risk sub-populations, has often been qualitative, and where
quantitative—because of sample size constraints or the nature of the sub-populations
included—has rarely allowed for a strong comparison of sexual risk behaviors between
injection and non-injection drug users. To the extent that IDUs engage in more high-risk
sexual behavior with multiple, concurrent partners, compared to non-IDUs, they potentiate
the bridging of HIV from IDU to non-IDU populations and extend or prolong the
generalized epidemic. This brief report characterizes the sexual behavior of a sample of
IDUs in the coastal town of Malindi, Kenya and compares sexual risk behaviors among a
sample of IDUs and non-IDUs in order to add to our limited knowledge of this important
and growing source of new HIV cases in Kenya.
2. Methods
A Priority for Local AIDS Control Efforts (PLACE) study was conducted in Malindi, Kenya
from April to May 2010. The PLACE methodology is focused on identifying the areas
where HIV transmission is most likely to occur – priority prevention areas (PPAs) – and
identifying specific venues within the PPAs where people meet new sexual partners and
where IDUs can be reached. This methodology is based on epidemiology theory which
indicates that there is often geographic clustering of HIV transmission (Grassly et al., 2001;
Wasserheit and Aral, 1996; Weir et al., 2005) and has been described elsewhere (Weir et al.,
2004). The PLACE method has been implemented in over 60 countries and has been shown
to be more effective in capturing the individuals with riskier sexual behaviors compared to
household surveys (Speizer et al., 2009; Tate et al., 2010; Weir et al., 2004).
Briefly, PLACE involves identifying venues and events where people are believed to
frequent to meet new sexual partners and places where IDUs can be reached. Interviewers
approach potential community informants (types of people, based on occupation, identified
by the local PLACE implementing team as being knowledgeable about venues in the PPA)
and request that they list the places where people are believed to meet new sexual partners
and where IDUs can be reached in their local area. Informants were also asked where IDUs
specifically meet new partners. Common types of informants were health care workers,
beer/liquor store owners, mobile hawkers/street vendors, taxi drivers, program coordinators,
peer educators, and business people.
Each venue/event was visited and verified: 202 community informants listed 157 unique
venues. At each of the venues a representative was surveyed to obtain information about the
venue, the people who socialize there, existing HIV prevention activities, and the
willingness to have such activities. The venue representative was typically an owner or
manager or someone who worked at the venue (or near the venue in the case of open spaces)
and was knowledgeable about the people who typically socialize at that venue. The venue
representative reported the venue size, which was considered to be the total number of
persons socializing at the venue during a busy time.
Next, the characteristics of people socializing or working at the sites were obtained via
survey sampling. Venues/events were randomly selected using a systematic fixed interval
sampling strategy with the probability of selection proportional to the size of the venue.
Venues and events were listed by both geographic code and size. Large venues could be
selected more than once if their cluster code number (determined by venue size) was larger
than the selection interval. The systematic fixed interval sampling strategy produced a self-
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weighted sample which gives all individuals socializing and working at eligible venues an
equal probability of selection for an individual interview. Probability proportional-to-size
was then used to select 29 venues/events in Malindi. An additional 10 venues were
identified by community informants as places where IDUs socialize. All of these venues
were visited to ensure a sufficient sample size of IDUs.
Local interviewers were trained on the rationale, objectives and methods for systematically
selecting and interviewing venue patrons, and they were provided a step-by-step interviewer
guide explaining how to complete each interview question. Interviewers selected 20
individuals (10–13 men, 7–10 women) to interview at each of the selected venues and 4
workers (2 male, 2 female). The numbers of men and women to interview were based on the
gender composition of socializers at each venue, which was obtained from the venue
representative survey. For those sites with more than 20 individuals, interviewers
systematically selected every ith individual socializing along an imaginary diagonal line
traversing different locations within the venue, where i is the sampling interval, or total
number of individuals at the venue divided by the number of interviews (20) required. For
those sites with fewer than 20 individuals and fewer than four workers, all were interviewed.
At some of the very small venues, interviewers waited for more socializers to arrive. All
individuals aged 18 and older were eligible for interview. Those aged 16 or 17 could be
interviewed if they were at the venue as a socializer without a parent (acting as an adult) and
not on a family errand. IDUs were asked to self-identify and were restricted to those
indicating they had injected drugs within the past year. Injecting practices of IDUs were
obtained via an Injection Drug Use Module including five (in some cases multipart)
questions eliciting drug injecting behaviors. The module included questions about how the
respondent typically injects (individually, with the same group, with different groups);
whether he/she shared a syringe at last injection; whether he/she shared a syringe, injected
from a common reservoir, used a ready-made solution without boiling, or exchanged a used
for a new syringe in the past month; the total number of people with whom he/she shared a
syringe in the past month, and of those, the number with whom he/she shared for the first
time; and whether new syringes are available when wanted. The module did not differentiate
between receptive needle sharing (risk to self) and distributive needle sharing (risk to
others), an acknowledged limitation of our study. Ethical approval was given by the
Kenyatta National Hospital Ethical Review Committee and the University of North Carolina
at Chapel Hill Institutional Review Board.
The study included voluntary testing and counseling (VCT) for HIV. Study participants
were told at the beginning and again at the end of the survey that they could be tested for
HIV if they chose to do so. Testing was done immediately following the survey in most
cases. Those who agreed to be tested were taken to a quiet room in the venue or a nearby
venue. In some cases, a tent was pitched outside the venue for privacy. VCT was done by
experienced and trained counselors. Individuals could receive their results immediately or
could call for their results at a later time. All HIV positive individuals were referred to the
nearest VCT center for follow-up counseling and guidance on treatment options. Some
individuals chose to answer the questionnaire but were not reached for HIV testing.
Information on HIV prevalence among IDUs was not available at the time of writing.
The analysis sample was restricted to non-MSM males because the IDUs were almost
exclusively male and because we were interested in isolating the risk in IDU versus non-
IDU populations. We performed simple univariate analyses of the IDU Module variables in
the IDU population and bivariate comparisons on IDU status for the demographic and sexual
risk behavior variables. A composite indicator meant to capture sexual risk is often
presented in PLACE studies. This indicator is based on the number of new and total partners
reported in the past 4 weeks and 12 months. Respondents are classified as having high,
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moderate or low rates of sexual partnerships based on the following classification: high –
new partner in past 4 weeks or multiple partners in past 4 weeks; moderate – new or
multiple partners in the past 12 months; low – no new partners or no multiple partners in
past 12 months. Rank sum and chi-square tests are used to test for statistical significance in
bivariate analyses. Multivariate logistic regressions were performed using number of sexual
partners and new sexual partners in the past year as dependent variables, IDU status as the
predictor variable, and age, secondary or greater education level, urban/rural residence, and
poverty status as covariates. In keeping with international definitions, a person was
considered to be living in poverty if he/she lived on less than $1.25 per day. Poverty was
self-reported using the survey question “How much money did you make from all sources in
the past 4 weeks? (Include income from all sources)” and reported in Kenya Shillings.
3. Results
Demographic and sexual risk behavior characteristics of the non-MSM male IDUs and non-
IDUs are shown in Table 1. IDUs in Malindi were more likely to be 34+ years old (p < .01),
less educated (p < .001), and urban residents (p < .01). They were also more likely to report
two or more sexual partners in the past year (p < .05), two or more new partners in the past
year (p < .01), and a higher composite sexual risk score (p < .05) compared to non-IDUs.
Over 70% of IDUs reported injecting within the past week and 84% reported injecting
within the past month (Table 2). The majority (52%) reported injecting alone and another
33% reported usually injecting with the same group. Nearly half (48%) indicated that they
shared a syringe the last time they injected, and almost the same percentage reported sharing
a syringe in the past month. During the past month 43% reported taking drugs from a
common reservoir, 49% used a ready-made solution without boiling, and 44% had not
exchanged a used for a new syringe. Over 20% of the IDUs reported sharing a syringe with
between one and three different people in the past month, 6% reported sharing with four to
five different people, 8% reported sharing with six to nine different people, and 6% reported
sharing with 10 or more different people. Of those who reported sharing a syringe, 23%
reported sharing with one to three different people for the first time, and another 4% with
between four and 10 different people for the first time. Most IDUs reported that they could
only inconsistently or never get new syringes when they wanted them. In multivariate
logistic regression models controlling for age, secondary education or higher, urban/rural
residence, and poverty status, IDUs were twice as likely as non-IDUs to report multiple
partners in the past year (OR 1.94, 95% CI 1.26 – 3.00, p < .01) and multiple new partners in
the past year (OR 2.11, 95% CI 1.30 – 3.42, p < .01).
4. Discussion
This brief report confirms the increased prevalence of multiple sexual partnerships and new
partnerships, the high prevalence of risky drug injecting behaviors, and the difficulty
obtaining new injecting needles in a sample of IDUs in Malindi, Kenya, all of which
increase the likelihood of HIV transmission. It is unclear exactly why IDUs were twice as
likely to engage in risky sexual practices. A qualitative study in South Africa (Parry et al.,
2009) detected a complex, context-specific relationship between drug use and sexual
behaviors and provides some insights. Many IDUs in that study used heroin, a depressant
that tends to inhibit libido, especially in large quantities or with long-term use, but
additionally consumed stimulant-type drugs such as crystal methamphetamine and Ecstasy
that increased sexual desire. Sexually active interviewees reported more sexual partners
(which included regular partners, friends, drug dealers, and strangers) when on drugs. Males
(both non-IDUs and IDUs) exchanged drugs for sex with sex workers for free or with
sexually available women, even if they were already involved in relationships. And despite a
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general awareness that unsafe sex could lead to HIV, substance use impaired judgment
regarding condom use and other safe sexual practices. A recent study among IDUs in
Tanzania reported an HIV seroprevalence rate of 42%, and in multivariate models the
strongest independent predictor of testing HIV-positive was having had sex 81 or more
times in the past month, which increased the probability approximately six times (Williams
et al., 2009).
Such findings point to an urgent need to seek out this marginalized population with the nine
proven effective interventions for the prevention, treatment, and care of HIV in IDUs
endorsed by UNAIDS, WHO, and UNODC (WHO et al., 2009): needle and syringe
programmes; opioid substitution therapy and other drug dependence treatment; HIV testing
and counselling; antiretroviral therapy; prevention and treatment of sexually transmitted
infections; condom programmes for IDUs and their sexual partners; targeted information,
education and communication for IDUs and their sexual partners; vaccination, diagnosis and
treatment of viral hepatitis; and prevention, diagnosis and treatment of tuberculosis. A
welcomed recent development in this direction is that the Kenyan Government has agreed to
provide such a comprehensive package of HIV services for IDUs, beginning in Mombasa
and extending to other regions of the country (United Nations Office on Drugs and Crime,
2011). A recent modeling study indicates that eliminating laws prohibiting opioid
substitution and scaling up of such services to 80% coverage in Nairobi could prevent 14%
of incident HIV infections in IDUs (Strathdee et al., 2010).
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Table 1
Demographic and sexual risk behavior characteristics of non-MSM male IDUs vs. non-IDUs in the Malindi
PLACE sample
Non-IDUs N=377 IDUs N=124
n (%) n (%)
Age
 15–24 120 (31.9) 21 (16.9)
 25–34 169 (45.0) 69 (55.6)
 34+ 87 (23.1) 34 (27.4)**
Currently working
 Yes 335 (89.1) 111 (90.2)
 No 41 (10.9) 12 (9.8)
Highest level of education
 None 68 (18.0) 47 (38.2)
 Primary 157 (41.6) 57 (46.3)
 Secondary+ 152 (40.3) 19 (15.4)***
Residence
 Urban 345 (92.7) 122 (99.2)
 Rural 27 (7.3) 1 (0.8)**
Marital status
 Ever married 212 (57.4) 73 (59.4)
 Never married 157 (42.6) 50 (40.6)
Poverty status
 In poverty 56 (15.0) 17 (13.8)
 Not in poverty 316 (85.0) 106 (86.2)
Number of partners in past 4 weeks
 0 103 (27.4) 38 (30.6)
 1 200 (53.2) 49 (39.5)
 2+ 73 (19.4) 37 (29.8)
Number of partners in past 12 months
 0 31 (8.2) 13 (10.5)
 1 187 (49.7) 40 (32.3)
 2+ 158 (42.0) 71 (57.3)*
Number of new partners in past 4 weeks
 0 283 (75.7) 91 (73.4)
 1 70 (18.7) 26 (21.0)
 2+ 21 (5.6) 7 (5.6)
Number of new partners past 12 months
 0 207 (55.4) 50 (40.3)













Brodish et al. Page 9
Non-IDUs N=377 IDUs N=124
n (%) n (%)
 1 90 (24.1) 34 (27.4)
 2+ 77 (20.6) 40 (32.3)**
Given/received money for sex in past 12 months
 No 300 (81.1) 100 (82.6)
 Yes 70 (18.9) 21 (17.4)
Condom use at last intercourse
 No 291 (80.8) 107 (87.7)
 Yes 69 (19.2) 15 (12.3)
Composite risk
 Low 176 (46.7) 44 (35.5)
 Moderate 90 (23.9) 32 (25.8)
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Table 2
Characteristics of non-MSM male IDUs in the Malindi PLACE sample
n (%)
When last injected drugs
 Within past 7 days 91 (73.4)
 Within past 2–4 weeks 13 (10.5)
 Within past 2–6 months 12 (9.7)
 Within past 7–12 months 8 (6.4)
With whom do you usually inject drugs?
 Individually 64 (52.5)
 Usually with the same group 40 (32.8)
 With different groups 15 (12.3)
 Depends on circumstances 3 (2.5)
Shared syringe last time injected
 Yes 58 (47.5)
 No 64 (52.5)
During the past 4 weeks…
 Shared a syringe
  Yes 50 (42.0)
  No 69 (58.0)
 Took drugs from common reservoir
  Yes 51 (42.9)
  No 68 (57.1)
 Used ready-made solution without boiling
  Yes 58 (48.7)
  No 61 (51.3)
 Exchanged a used for a new syringe
  Yes 66 (55.9)
  No 52 (44.1)
 Number of different people you shared a syringe with
  0 69 (56.1)
  1–3 29 (23.6)
  4–5 8 (6.5)
  6–9 10 (8.1)
  10+ 7 (5.7)
 Number of those people you shared a syringe with for the first time
  0 90 (73.2)
  1–3 28 (22.8)
  4–5 3 (2.4)
  6–9 1 (0.8)
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n (%)
  10+ 1 (0.8)
Can you get new syringes whenever you want?
 Always 55 (45.4)
 Sometimes 62 (51.2)
 Never 4 (3.3)
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